Vamil Divan
Stock Analyst at Guggenheim
Total Price Targets
22
Stocks Covered
13
Sectors
Healthcare, Technology
Most Recent
Apr 10, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Vamil Divan
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | $249.00 | $206.29 | +20.7% | 3 | Apr 10, 2026 |
| JNJ | Johnson & Johnson | $240.00 | $227.97 | +5.3% | 2 | Jan 23, 2026 |
| ANIP | ANI Pharmaceuticals, Inc. | $124.00 | $80.00 | +55.0% | 2 | Jan 16, 2026 |
| TVTX | Travere Therapeutics, Inc. | $49.00 | $44.19 | +10.9% | 3 | Jan 14, 2026 |
| EOLS | Evolus, Inc. | $19.00 | $5.29 | +259.5% | 2 | Dec 1, 2025 |
| JBIO | Jade Biosciences, Inc. | $14.00 | $24.43 | -42.7% | 1 | Jun 16, 2025 |
| ALKS | Alkermes plc | $40.00 | $33.49 | +19.4% | 2 | Nov 13, 2024 |
| KROS | Keros Therapeutics, Inc. | $96.00 | $11.48 | +736.2% | 1 | Sep 23, 2024 |
| EXLS | ExlService Holdings, Inc. | $25.00 | $31.86 | -21.5% | 1 | Sep 9, 2024 |
| PFE | Pfizer Inc. | $36.00 | $26.38 | +36.5% | 2 | Jul 30, 2024 |
| INSM | Insmed Incorporated | $95.00 | $133.75 | -29.0% | 1 | Jul 9, 2024 |
| SVRA | Savara Inc. | $5.00 | $5.13 | -2.6% | 1 | Jun 27, 2024 |
| LLY | Eli Lilly and Company | $356.00 | $961.67 | -63.0% | 1 | May 3, 2022 |
Recent Activity
- Apr 10, 2026— Set$249.00price target onABBV(AbbVie Inc.)
- Jan 23, 2026— Set$240.00price target onJNJ(Johnson & Johnson)
- Jan 16, 2026— Set$124.00price target onANIP(ANI Pharmaceuticals, Inc.)
- Jan 14, 2026— Set$49.00price target onTVTX(Travere Therapeutics, Inc.)
- Dec 1, 2025— Set$19.00price target onEOLS(Evolus, Inc.)
- Sep 8, 2025— Set$114.00price target onANIP(ANI Pharmaceuticals, Inc.)
- Jun 16, 2025— Set$14.00price target onJBIO(Jade Biosciences, Inc.)
- Feb 3, 2025— Set$166.00price target onJNJ(Johnson & Johnson)
- Nov 13, 2024— Set$40.00price target onALKS(Alkermes plc)
- Sep 27, 2024— Set$23.00price target onTVTX(Travere Therapeutics, Inc.)
- Sep 23, 2024— Set$96.00price target onKROS(Keros Therapeutics, Inc.)
- Sep 13, 2024— Set$25.00price target onEOLS(Evolus, Inc.)
- Sep 9, 2024— Set$25.00price target onEXLS(ExlService Holdings, Inc.)
- Sep 9, 2024— Set$12.50price target onTVTX(Travere Therapeutics, Inc.)
- Jul 30, 2024— Set$36.00price target onPFE(Pfizer Inc.)
- Jul 9, 2024— Set$95.00price target onINSM(Insmed Incorporated)
- Jun 27, 2024— Set$5.00price target onSVRA(Savara Inc.)
- Apr 9, 2024— Set$35.00price target onALKS(Alkermes plc)
- May 9, 2023— Set$171.00price target onABBV(AbbVie Inc.)
- May 3, 2022— Set$356.00price target onLLY(Eli Lilly and Company)
Frequently Asked Questions
Who is Vamil Divan?
Vamil Divan is a stock analyst at Guggenheim covering 13 stocks primarily in Healthcare, Technology. They have issued 22 price targets since Feb 6, 2022.
What stocks does Vamil Divan cover?
Vamil Divan currently covers 13 stocks, including ABBV, TVTX, JNJ, ANIP, EOLS.
What is Vamil Divan's latest price target?
Vamil Divan's most recent price target was $249.00 on ABBV (AbbVie Inc.), set on Apr 10, 2026.
What is Vamil Divan's highest price target?
Vamil Divan's highest issued price target is $356.00 on LLY, set on May 3, 2022.
More Analysts at Guggenheim
Coverage based on publicly published price targets. Not investment advice.